Oncology Treatment Related Ocular Surface Changes
NCT07666724
·
clinicaltrials.gov ↗
COMPLETED
Status
35
Enrollment
OTHER
Sponsor class
Conditions
Breast Neoplasm, Exercise
Interventions
DRUG:
Trastuzumab (Herceptin)
Sponsor
Semmelweis University